BlackRock Updates Passive Stake in Inspire Medical Systems
Ticker: INSP · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investing, amendment
TL;DR
**BlackRock just updated its passive stake in Inspire Medical Systems, showing continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Inspire Medical Systems, Inc. common stock as of December 31, 2023. This filing, Amendment No. 3, updates previous disclosures about BlackRock's passive investment in the medical device company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in the stock's future performance, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's continued, albeit updated, passive investment in Inspire Medical Systems, Inc., which can be seen as a vote of confidence from a major institutional player.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued presence as a passive holder, but this filing alone doesn't suggest a need for immediate action. It's a routine update, not a major shift in strategy.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Inspire Medical Systems, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 3 (number) — the specific amendment number of the filing
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Inspire Medical Systems, Inc. throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company of this filing?
The subject company is Inspire Medical Systems, Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.' and 'INSPIRE MEDICAL SYSTEMS INC (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement)'.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding Inspire Medical Systems, Inc. (INSP).